Compound
D0607 | 1-dodecyl-3-methylimidazolium hexafluorophosphate
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 3.71±8.52 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 5.01 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 8.81±2.46 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 1-Dodecyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V); | 1-Dodecyl-3-methylimidazolium hexafluorophosphate | 219947-93-0 |
| AK402421 | AKOS030228352 | CAS-219947-93-0 |
| CHEMBL3187264 | CTK3J6688 | DSSTox_CID_27895 |
| DSSTox_GSID_47919 | DSSTox_RID_82648 | DTXSID4047919 |
| KS-00000ZRO | KSC496M8R | NCGC00248754-01 |
| NCGC00258150-01 | Q-102688 | RT-003189 |
| Tox21_200596 | ZB1675 |
| CAS Number | 219947-93-0 |
| PubChem Compound | 10250129 |